Does use of alternative medicine predict survival from cancer?

European Journal of Cancer

Volumn 39, Issue 3, 2003, Pages 372-377

  Risberg, T ^a   Vickers, A ^d   Bremnes, R M ^a   Wist, E A ^b   Kaasa, S ^c   Cassileth, B R ^d  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^d NONE

Author keywords

Alternative medicine; Performance status; Prognosis; Survival

Indexed keywords

ADOLESCENT; ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; CANCER SURVIVAL; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HAZARD ASSESSMENT; HUMAN; MALE; MORTALITY; MULTICENTER STUDY; PERFORMANCE; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; SENSITIVITY ANALYSIS;

EID: 0037306479     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00701-3     Document Type: Article

References (21)

1. Astin J.A. Why patients use alternative medicine. results of a national study JAMA. 279:1998;1548-1553.
2. Lerner I.J. The whys of cancer quackery. Cancer. 538(Suppl. 3):1984;15-19.
3. Cassileth B.R., Chapman C.C. Alternative and complementary cancer therapies. Cancer. 77:1996;1026-1034.
4. van der Zouwe N., van Dam F.S., Aaronson N.K., Hanewald G.J. Alternative treatments in cancer; extent and background of utilization. Ned Tijdschr Geneeskd. 138:1994;300-306.
5. Stoll B.A. Can unorthodox cancer therapy improve quality-of-life? Ann. Oncol. 4:1993;121-123.
6. Risberg T., Kaasa S., Wist E., Melsom H. Why are cancer patients using non-proven complementary therapies? A cross-sectional multicentre study in Norway. Eur. J. Cancer. 33:1997;575-580.
7. Downer S.M., Cody M.M., McCluskey P.et al. Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ. 309:1994;86-89.
8. Davidson J.R., Rampes H., Eisen M., Fisher P., Smith R.D., Malik M. Psychiatric disorders in primary care patients receiving complementary medical treatments. Compr. Psychiatry. 39:1998;16-20.
9. Burstein H.J., Gelber S., Guadagnoli E., Weeks J.C. Use of alternative medicine by women with early-stage breast cancer. N. Engl. J. Med. 340:1999;1733-1739.
10. Carlsson M., Arman M., Backman M., Hamrin E. Perceived quality of life and coping for Swedish women with breast cancer who choose complementary medicine. Cancer Nurs. 24:2001;395-401.
11. Sollner W., Maislinger S., DeVries A., Steixner E., Rumpold G., Lukas P. Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior. a survey Cancer. 89:2000;873-880.
12. Risberg T., Lund E., Wist E., Kaasa S., Wilsgaard T. Cancer patients use of nonproven therapy. a 5-year follow-up study J. Clin. Oncol. 16:1998;6-12.
13. Risberg T., Lund E., Wist E., Dahl O., Sundstrom S., Andersen O.K.et al. The use of non-proven therapy among patients treated in Norwegian oncological departments. A cross-sectional national multicentre study. Eur. J. Cancer. 31A:1995;1785-1789.
14. Andrews F.M., Withey S.B. Social Indicatior of Well-Being. Americans' Perceptions of Life Quality. 1976;Plenum Press, New York.
15. Holmen J, Midthjell K, Bjartveit K, et al. The North-Trondelag Health Survey 1984-1986. Purpose, Background and Methods. Participation, Non-Participation and Frequency Distributions, Vol. 4. Verdal, Norway: National Institute of Public Health, Community Medicine Research Centre 1990.
16. Stein Kaasa, Arne Masterkaasa, Eilif Lund. Prognostic factors for patients with inoperable non-small cell lunge cancer, limited disease. The importance of patients' subjective experience of disease and psychosocial well-being. Radiother Oncol 1989, 15, 235-242.
17. Risberg T., Lund E., Wist E. Use of non-proven therapies. Differences in attitudes between Norwegian patients with non-malignant disease and patients suffering from cancer. Acta Oncol. 34:1995;893-898.
18. Cassileth B.R., Lusk E.J., Strouse T.B., Bodenheimer B.J. Contemporary unorthodox treatments in cancer medicine. A study of patients, treatments, and practitioners. Ann. Intern. Med. 101:1984;105-112.
19. Coates A., Porzsolt F., Osoba D. Quality of life in oncology practice. prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy Eur. J. Cancer. 33:1997;1025-1030.
20. Chang V.T., Thaler H.T., Polyak T.A., Kornblith A.B., Lepore J.M., Portenoy R.K. Quality of life and survival. the role of multidimensional symptom assessment Cancer. 83:1998;173-179.
21. Ganz P.A., Lee J.J., Siau J. Quality of life assessment. An independent prognostic variable for survival in lung cancer. Cancer. 67:1991;3131-3135.